TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -2 | -2 | -2 | 7 | 22 | 36 | 10 |
| S | %wins | 100 | 67 | 33 | 33 | 0 | 0 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/22/07 09:38 | 3/20/07 | BIIB | Biogen Idec Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kellogg Peter N | MA | O | EVP,Fina | S | -323 | 44.48 | 33 | -7 | -28 | 19 | D | 20 | -7 | 5 | -11 | -7 | 3 | 4 | 5 | -1 | -2 | 2 | 12 | 47 | 29 |
2/15/07 15:20 | 2/13/07 | BIIB | Biogen Idec Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kellogg Peter N | MA | O | EVP,Fina | S | -502 | 49.22 | 33 | -10 | -35 | 19 | D | -24 | 16 | 21 | 6 | 2 | 6 | 3 | 2 | -5 | -7 | -14 | -7 | 16 | 25 |
9/20/06 16:01 | 9/19/06 | BIIB | Biogen Idec Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kellogg Peter N | MA | O | EVP,Fina | S | -943 | 42.78 | 33 | -22 | -56 | 17 | D | -30 | 7 | -11 | -4 | 3 | -3 | -2 | 0 | 0 | 2 | 5 | 15 | 4 | 54 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |